Stockholm, Sweden

ESTRO 2026

Session

Preclinical biomarkers
Digital Poster
Radiobiology
Whole genome analysis for identification of non-coding G-quadruplex mutations in Pan-Cancer
Amen Shamim, United Kingdom
-912
MRI-based radiomics enables prediction of tumor control after radiotherapy in non-small cell lung cancer (NSCLC) subcutaneous xenograft models
Sona Michlikova, Germany
-1499
TGF-? as a biomarker of radiotherapy response in ductal carcinoma in situ
Katja Goričar, Slovenia
-1778
Association Between Androgen Receptor Expression and Tumor Volume in Glioblastoma
Larysa Liubych, Germany
-2091
Uncovering CCDC97 role in radiotherapy response of ER+ breast cancer cells
Assia Duatti, Italy
-2752
Catabolic crosstalk index (zCCI): A RNAseq biomarker that could quantify tumour–muscle signalling in pancreatic and liver cancer
Ahmed Salem, Jordan
-3993
Dynamic optical coherence tomography radiomics for high-throughput, non-invasive assessment of radiation damage in spheroids
Mark Arndt, Germany
-4750
Monitoring tumor oxygenation to improve radiotherapy outcomes for non-small cell lung cancer (NSCLC)
Vansh Sandhu, Canada
-4989
Unsupervised clustering of histopathological images from xenograft tumors links keratin to radiosensitivity of head and neck squamous cell carcinoma
Sona Michlikova, Germany
-5144